Clrb stock website
Cellectar Biosciences (NasdaqCM:CLRB) - Share price, News ... The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey. Show less Cellectar Biosciences, Inc. Common Stock (CLRB) Insider ... Feb 14, 2020 · Find the latest Insider Activity data for Cellectar Biosciences, Inc. Common Stock (CLRB) at Nasdaq.com. Looking for additional market data? it is recommended to visit the company's website CLRB:NASDAQ CM Stock Quote - Cellectar Biosciences Inc ...
Mar 02, 2020 · CLRB Ownership Overview. Cellectar Biosciences, Inc. (CLRB) Ownership Summary provides a snapshot of institutional holdings and activity for a particular stock. The institutional holdings summary data encompasses the holdings and change from most recent 13F filings.
CLRB - Cellectar Biosciences Summary, Stock ... - Benzinga Jan 01, 2010 · Cellectar Biosciences (Nasdaq: CLRB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers CLRB Stock Price, Forecast & News (Cellectar Biosciences) Analyzing Cellectar Biosciences (NASDAQ:CLRB) stock? View CLRB's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. An investor that had 100 shares of Cellectar Biosciences stock prior to the reverse split would have 10 shares after the split.
Cellectar Biosciences (CLRB) Stock: Gaining On ...
The Distribution Yield is the trailing 12-Month End Yield derived by adding the trailing 12-month's income distributions and dividing the total by the last month's ending share price. Income refers to interest payments from fixed-income ETFs and dividend payments from stock-based ETFs. CLRB Stock Price and Chart — NASDAQ:CLRB — TradingView — … TradingView India. View live CELLECTAR BIOSCIENCES INC chart to track its stock's price action. Find market predictions, CLRB financials and market news. CLRB YTD Return The CLRB YTD return is shown above. The YTD Return on the CLRB YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session).
Product Pipeline :: Cellectar Biosciences, Inc. (CLRB)
LRB stock | wheeleraccuracy This stock is the product of input from some of the best long range Benchrest shooters in the world. This is the best tracking stock available due to the adjustable rudder system and 4" forend. It is designed to shoot free recoil or with a hold. $CLRB Stock Technical Analysis | Cellectar | SwingTradeBot.com Nov 12, 2019 · Cellectar Biosciences, Inc., a development stage biopharmaceutical company, develops compounds for the treatment and imaging of cancer. Its proprietary product candidates include I-124-CLR1404, a small-molecule, broad-spectrum, and cancer-targeting positron emission tomography (PET) imaging agent that is in Phase II clinical trial for glioblastoma, as well as in Phase I/II clinical trials for
CLRB Stock Price and Chart — NASDAQ:CLRB — TradingView
A fast and easy way to analyze US Stocks Technical analysis gauges display real-time ratings for the selected timeframes. The summary for CELLECTAR BIOSCIENCES INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Cellectar Biosciences (CLRB) Stock: Rocketing On FDA News ...
If you follow Cellectar Biosciences (NASDAQ: CLRB), you’ve seen a pretty rough few days. In fact, over this period, the stock has given up about 30% of its value. While declines can happen for many reasons, this particular fall in value was unwarranted. In fact, the drop in value seems to be the result of […] Cellectar Biosciences, Inc. (CLRB) Company Profile & Facts ... See the company profile for Cellectar Biosciences, Inc. (CLRB) including business summary, industry/sector information, number of employees, business … CLRB | Cellectar Biosciences Inc. Stock Price & News - WSJ View the latest Cellectar Biosciences Inc. (CLRB) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dow Jones, a News Corp company.